Practical implementation of a modified continual reassessment method for dose-finding trials S. PiantadosiJ. D. FisherS. Grossman ORIGINAL ARTICLE Pages: 429 - 436
Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid Anna KruczynskiFrancis ColpaertBridget T. Hill ORIGINAL ARTICLE Pages: 437 - 447
Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines Edith A. PerezChristopher A. Buckwalter ORIGINAL ARTICLE Pages: 448 - 452
Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer Yoichi NakanishiYuji KawaradaFukuoka Lung Cancer Study Group ORIGINAL ARTICLE Pages: 453 - 456
Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2′-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin Mary Jane ElliottLolita StribinskieneRichard B. Lock ORIGINAL ARTICLE Pages: 457 - 463
Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates Susan M. BlaneyChris TakimotoFrank M. Balis ORIGINAL ARTICLE Pages: 464 - 468
Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line Hetty Timmer-BosschaElisabeth G. E. de VriesNanno H. Mulder ORIGINAL ARTICLE Pages: 469 - 476
Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer Joel M. ReidJohn S. KovachCharles G. Moertel ORIGINAL ARTICLE Pages: 477 - 484
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents Claire A. CogginsGertrude B. ElionHenry S. Friedman ORIGINAL ARTICLE Pages: 485 - 490
Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells G. P. RaaphorstJ. MiaoC. E. Ng ORIGINAL ARTICLE Pages: 491 - 496
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models Roy S. HerbstHideya TakeuchiBeverly A. Teicher ORIGINAL ARTICLE Pages: 497 - 504
Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo Gregory P. ZagajaManeesh ShrivastavMatthew F. Fleig ORIGINAL ARTICLE Pages: 505 - 512
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study Paolo PronzatoPierluigi LosardoAlessandra Tognoni CLINICAL TRIAL REPORT Pages: 513 - 516
Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits Tanja CuferIvan VrhovecBranimir I. Sikic SHORT COMMUNICATION Pages: 517 - 521
